Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE

Fig. 2

Change from baseline in MHD – Overall population and by migraine type. MHD, monthly headache/migraine days; SD, standard deviation. Mean ± standard error values are plotted and baseline MHD (SD) are provided for each plot. The total number of evaluable subjects at the respective visit in the full analysis set are presented below each plot. Baseline is defined as the last observation on the day of or before the first dose of the study drug. After baseline, only patients with a value at both baseline and the respective month are included

Back to article page